Prescription Drug Affordability Act of 2005
Latest action · Feb 25, 2005 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedFeb 2, 2005
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Prescription Drug Affordability Act of 2005 - Amends title XVIII (Medicare) of the Social Security Act to require the Secretary of Health and Human Services to negotiate with covered drug manufacturers and disclose the lowest possible prices for prescription drugs under the new Medicare prescription drug program.
Directs the Secretary, acting through the Commissioner of Food and Drugs, with respect to the importation by Medicare beneficiaries of prescription drugs from Canada, to provide waivers that permit such beneficiaries to import prescription drugs from Canada.
Cosponsors
Members who signed on, in the order they did.
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Feb 2, 2005 |
| Health Subcommittee | Referred Feb 25, 2005 | |
| House | Ways and Means Committee | Referred Feb 2, 2005 |
| Health Subcommittee | Referred Feb 14, 2005 |
Actions 4
Everything that happened, newest first.
- Feb 25, 2005Referred to the Subcommittee on Health.
- Feb 14, 2005Referred to the Subcommittee on Health.
- Feb 2, 2005Introduced in House
- Feb 2, 2005Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
CRS reports 1
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 1
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| RL32961 | Veterans’ Health Care Issues in the 109th Congress Archived | Report | Oct 26, 2006 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend part D of title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate and disclose lowest possible prices for prescription drug prices for Medicare beneficiaries, and, with respect to the Federal Food, Drug, and Cosmetic Act, to provide waivers that permit such beneficiaries to import prescription drugs from Canada.
- Short Titles as Introduced
- Prescription Drug Affordability Act of 2005
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Administrative procedure
- Canada
- Commerce
- Cost control
- Department of Health and Human Services
- Drug approvals
- Drug industry
- Drugs
- Food and Drug Administration (FDA)
- Foreign Trade and International Finance
- Government Operations and Politics
- Government paperwork
- Government publicity
- Health
- Import restrictions
- Imports
- Law
- Licenses
- Medical records
- Medicare
- Pharmacies
- Prescription pricing
- Social Welfare
Text 1
Each version as it was printed, newest first.
- Feb 2, 2005Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.